1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Ecthyma: new trials by email Literature Review of Ecthyma trials Research Report on Ecthyma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream IMP2 (lidocaine-23%-tetracaine-7% gel), IMP1 (EMLA 5% cream) - Ulcus Cruris, Ecthyma | Phase 2 | Unknown | Juerg Hafner | 40 | 2023-06-01 | 2023-06-06 |
Foot Ulcer (1) · Leg Ulcer (1) · Varicose Ulcer (1)
Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Cardiovascular Diseases (1) · Foot Diseases (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Pyoderma (1) · Skin Diseases (1) · Skin Diseases, Bacterial (1) · Skin Diseases, Infectious (1) · Skin Ulcer (1) · Skin and Connective Tissue Diseases (1) · Streptococcal Infections (1) · Varicose Veins (1) · Vascular Diseases (1)
IGF2BP2 protein, human (1) · Lidocaine, Prilocaine Drug Combination (1) · signal peptide peptidase (1)
Juerg Hafner (1)
Switzerland (1)